Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells
- PMID: 16778186
- DOI: 10.1158/0008-5472.CAN-06-0404
Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells
Abstract
Hepatocellular carcinoma is a major cause of cancer-related deaths. Current treatments are not effective, and the identification of relevant pathways and novel therapeutic targets are much needed. Increasing evidences point to the activation of the epidermal growth factor receptor (EGFR) as an important mechanism in the development of hepatocarcinoma. We previously described that amphiregulin (AR), a ligand of the EGFR, is not expressed in healthy liver but is up-regulated during chronic liver injury, the background on which most liver tumors develop. Now, we have studied the expression and role of AR in human hepatocarcinoma. AR expression and function was studied in human liver tumors and cell lines. AR is expressed in human hepatocellular carcinoma tissues and cell lines and behaves as a mitogenic and antiapoptotic growth factor for hepatocarcinoma cells. We provide several lines of evidence, including AR silencing by small interfering RNAs and inhibition of amphiregulin by neutralizing antibodies, showing the existence of an AR-mediated autocrine loop that contributes to the transformed phenotype. Indeed, interference with endogenous AR production resulted in reduced constitutive EGFR signaling, inhibition of cell proliferation, anchorage-independent growth, and enhanced apoptosis. Moreover, knockdown of AR potentiated transforming growth factor-beta and doxorubicin-induced apoptosis. Conversely, overexpression of AR in SK-Hep1 cells enhanced their proliferation rate, anchorage-independent growth, drug resistance, and in vivo tumorigenic potential. These observations suggest that AR is involved in the acquisition of neoplastic traits in the liver and thus constitutes a novel therapeutic target in human hepatocarcinoma.
Similar articles
-
Amphiregulin: a new growth factor in hepatocarcinogenesis.Cancer Lett. 2007 Aug 28;254(1):30-41. doi: 10.1016/j.canlet.2007.01.015. Epub 2007 Feb 26. Cancer Lett. 2007. PMID: 17321672 Review.
-
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.Oncogene. 1999 Nov 11;18(47):6513-20. doi: 10.1038/sj.onc.1203042. Oncogene. 1999. PMID: 10597254
-
Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.Cancer Res. 2007 Feb 1;67(3):901-10. doi: 10.1158/0008-5472.CAN-06-2344. Cancer Res. 2007. PMID: 17283120
-
Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.Cancer Lett. 2007 Apr 8;248(1):32-40. doi: 10.1016/j.canlet.2006.05.018. Epub 2006 Jul 11. Cancer Lett. 2007. PMID: 16837130
-
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:213-9. doi: 10.1111/j.1440-1746.2010.06582.x. J Gastroenterol Hepatol. 2011. PMID: 21199533 Review.
Cited by
-
Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.J Cell Mol Med. 2016 Oct;20(10):1829-39. doi: 10.1111/jcmm.12873. Epub 2016 May 14. J Cell Mol Med. 2016. PMID: 27196940 Free PMC article.
-
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.Mol Cancer. 2010 Jan 24;9:13. doi: 10.1186/1476-4598-9-13. Mol Cancer. 2010. PMID: 20096135 Free PMC article.
-
Mechanisms of tumor resistance to EGFR-targeted therapies.Expert Opin Ther Targets. 2009 Mar;13(3):339-62. doi: 10.1517/14712590902735795. Expert Opin Ther Targets. 2009. PMID: 19236156 Free PMC article. Review.
-
Expression of Amphiregulin in Enchondromas and Central Chondrosarcomas.Clinics (Sao Paulo). 2021 Aug 27;76:e2914. doi: 10.6061/clinics/2021/e2914. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 34468540 Free PMC article.
-
Complement Membrane Attack and Tumorigenesis: A SYSTEMS BIOLOGY APPROACH.J Biol Chem. 2016 Jul 15;291(29):14927-38. doi: 10.1074/jbc.M115.708446. Epub 2016 May 19. J Biol Chem. 2016. PMID: 27226542 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous